Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology
暂无分享,去创建一个
A. Berchuck | A. Secord | J. Cragun | L. Havrilesky | D. Clarke‐Pearson | J. Soper | B. Calingaert | C. Lutman
[1] A. Berchuck,et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] L. Mack,et al. Controversies in the management of metastatic melanoma to regional lymphatic basins , 2004, Journal of surgical oncology.
[3] C. Pettaway,et al. The role of lymphadenectomy in penile cancer. , 2004, Urologic oncology.
[4] M. Maiman,et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study , 2004 .
[5] M. J. Webb,et al. Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. , 2003, Gynecologic oncology.
[6] J. Fanning. Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. , 2001, Gynecologic oncology.
[7] M. Kawai,et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. , 2001, Gynecologic oncology.
[8] M. J. Webb,et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? , 2000, American journal of obstetrics and gynecology.
[9] G. Calais,et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. , 1997, Gynecologic oncology.
[10] D. Gershenson,et al. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. , 1995, Gynecologic oncology.
[11] E. Partridge,et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. , 1995, Gynecologic oncology.
[12] M. Tattersall,et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer , 1993, International Journal of Gynecologic Cancer.
[13] R. Kurman,et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study , 1991 .
[14] B. Goff,et al. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. , 1990, Gynecologic oncology.
[15] B. Bundy,et al. Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.